Abstract
Viruses do not have their own energy supplying and structural-components synthesizing systems. That is the main difference between viruses and such pathogens as bacteria and rickettsia. Therefore they have to use intracellular structures and enzymes for their replication, so the critical stage of their reproduction is the stage at which they penetrate the cell. Once they have entered the cell viruses do not leave it until multiplying and fully maturating after which they can infect hundreds or even thousands of new cells. Bacteria do not really need cellular structures for their replication because their main requirements are energy sources and elementary structural components, such as amino acids, nucleic acids, carbohydrates, fatty acids or their components. The main, if not the only, way to defeat a virus is to attack it before it enters the living cell, whereas bacteria may be attacked throughout their life cycle taking place in a macroorganism. The time interval before a virus enters the eucaryotic cell or attacks the critical organ is sometimes prolonged. This allows the use of drugs or preparations for diminishing the symptoms or even for preventing the disease itself. One striking example has recently been sent for publication by researchers of our Center. The manuscript describes the preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infection [21]. In this chapter I would like to present some results from this publication, together with other data about preparations for post exposure prophylaxis of viral infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lange, G.V., McCormick, G.B., Walker, D.H. Kiley, M.P., and Neidhardt F.S. (1985) Vaccination of rhesus monkey by gamma-inactivated Ebola virus and results of live virus challenge in immune and native animalsAbstr. Ann. Meet. Amer. Soc. Microbiol.Las Vegas, Nevada, 3–7 March, 1985; CDC, Atlanta; p. 295.
Lupton, H.W., Lambert, R.D., Bumgardner, D.L., Moe, J.B., and Eddy, G.A. (1980) Inactivated vaccine for Ebola virus efficacious in guinea pig modelLancet 2(8207)1294–1295.
Mikhailov, V.V., Borisevich, I.V., Chernikova, N.K., Potryvaeva, N.V., and Krasnianskii, V.P. (1994) The evaluation in hamadyas baboons of the possibility for the specific prevention of Ebola feverVoprosy Virusologii(in Russian)39(2)82–84.
Ignatyev, G.M., Streltsova, M.A., Agafonov, A.P., and Kashentseva, E.A. (1995) Mechanisms of protective immune response in monkeys with Marburg virusVoprosy Virusologii(in Russian)40(3)109–113.
Chepurnov, A.A., Chernukhin, I.V., Ternovoi, V.A., Kudoiarova, N.M., Makhova, N.M., Azaev, M.S., and Smolina, M.P. (1995) Attempts to develop a vaccine against Ebola feverVoprosy Virusologii(in Russian)40 (6)257–260.
Merzlikin, N.V., Chepurnov, A.A., Istomina, N.N., Ofitserov, V.I., and Vorobyeva, M.S. (1995) Development and use of enzyme immunoassay test systems for the diagnosis of Ebola feverVoprosy Virusologii (in Russian) 40 (1)31–35.
Dedkova, L.M., Kudoiarova, N.M., Chepurnov, A.A., and Ofitserov, V.I. (1994) Composition and immunochemical properties of goat immunoglobulins against the Ebola virusVoprosy Virusologii (inRussian)39(5)229–231.
Moe, J.B., Lambert, R.D., and Lupton, H.W. (1981) Plaque assay for Ebola virusJ Clin. Microbial. 13 (4)791–793.
Cohn, E.J., Strong, L.E., and Hughes, W.L. (1946) Preparation and properties of serum and plasma proteins. IV. A System for the separation into fractions of the protein and lipoprotein components of biological tissues and fluidsJ. Amer. Chem. Soc.68 (3)459–475.
Van der Groen, G., Jacob, W., and Pattyn, S.R. (1979) Ebola virus virulence for newborn miceJ Med. Virol. 4 (3)239–240.
Krasnianskii, V.P., Mikhailov, V.V., Borisevich, I.V., Gradoboev, V.N., Evseev, A.A., and Pshenichnov, V.A. (1994) Preparation of hyperimmune horse serum against Ebola virusVoprosy Virusologii(in Russian)39 (2)91–92.
Ashmarin, I.P. and Vorob’ev, A.A. (1962)Statistical methods in microbiological investigationMedicine, Leningrad, p. 230. (in Russian)
Burgasov, P.N. (ed.) (1978) Handbook on vaccination and seroprophylaxis, Medicine, Moscow, p. 439 (in Russian)
Emond, R.T.D., Evans, B., Bowen, E.T.W., and Lloyd, G.N. (1977) A case of Ebola virus infectionBrit. Med. J. 2 (6086)541–544.
Dedkova, L.M., Kudoyarova, N.M., Shaprov, V.N., Sabirov, A.N., and Offitserov, V.I. (1993) Antibodies of hyperimmune sera of animals. II. Subclasses of Immunoglobulin G from normal and hyperimmune sera of goat Siberian Biological Journal (in Russian)68–13.
Borisevich, I.V., Mikhailov, V.V., Krasnianskii, V.P., Gradoboev, V.N., Lebedinskaia, Ye.V., Potryvaeva, N.V., and Timan’kova G.D. (1995) Development and study of the properties of immunoglobulin against Ebola feverVoprosy Virusologii (in Russian) 40 (6)270–273.
Markin, V.A., Mikhailov, V.V., Krasnianskii, V.P., Borisevich, I.V., and Firsova, I.V. (1997) Developing principles for emergency prevention and treatment of Ebola feverVoprosy Virusologii (in Russian) 42 (1)31–34.
Jahrling, P.B., Geisbert, J., Swearengen, J.R., Jaax, G.P., Lewis, T., Huggins, J.W., Schmidt, J.J., LeDuc, J.W., and Peters, C.J. (1996) Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horsesArchives of Virology Supplementum 11135–140.
Ryabchikova, E.I., Kolesnikova, L.V., Smolina, M., Tkachev, V.V., Pereboeva, L.V., Baranova, S.B., Grazhdantseva, A.A., and Rassadkin, Yu.N. (1996) Ebola virus infection in guinea pigs: presumable role of granulomatosis inflammation ill pathogenesisArchives of Virology 141 (5)909–922.
Fields, B.N., Knipe, D.M., Howley, P.M. (eds) (1996)Fields VirologyRaven Publishers, Philadelphia/New York.
Kudoyarova-Zubavichene, N.M., Sergeyev, N.N., Chepurnov, A.A., and Netesov, S.V. (1999) Preparation and Use of hyperimmune serum for prophylaxis and therapy of Ebola virus infection,.Journal of Infectious Diseases179SupplIS218–223.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Netesov, S.V. (2001). The Post Exposure Prophylactic Measures Against Viral BTW Agents. In: Kelle, A., Dando, M.R., Nixdorff, K. (eds) The Role of Biotechnology in Countering BTW Agents. NATO Science Series, vol 34. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0775-7_20
Download citation
DOI: https://doi.org/10.1007/978-94-010-0775-7_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6906-6
Online ISBN: 978-94-010-0775-7
eBook Packages: Springer Book Archive